Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.
Related Reports Special Report: Newly Competitive Gaucher’s Disease Marketplace Showcases Strategies for Rare Diseases SPECIAL REPORT: Dealmaking and Industry Outlook in Niche Metabolic Diseases Executing Change: Survival Strategies of Big Biotech
See which reports have been searched on the most.
September 9, 2010
Increased Uptake of Currently-Available Therapies Will Drive Modest $400 Million Growth in the Parkinson’s Disease Drug Market from 2009 to 2019
September 8, 2010
Driven by Sales of Lyrica, Cymbalta/Xeristar and Savella, the Fibromyalgia Drug Market Will Experience 4.2 Percent Annual Growth Through 2018
September 7, 2010
Owing to Increased Access to Medical Care and a Growing Drug-Treated Population, the Liver Cancer Drug Market in China Will Nearly Triple From $53 million in 2009 to $144 million in 2014
Human Immunodeficiency Virus (HIV) (Event Driven)
Last Updated 9 September 2010The HIV market is highly dynamic, with one of the most active pipelines,... Read More
Psoriasis (Event Driven)
Last Updated 3 September 2010Despite the major impact psoriasis has on patients’ quality of life, physicians... Read More
Pharmaceutical Pricing, Reimbursement, and Market Access News in the Second Quarter of 2010
The second quarter of 2010 built on an exceptionally eventful first quarter with regard to pharmaceutical pricing,... Read More